Highlights
- Fourth Quarter 2025 revenue of
$642.3 million , flat year-over-year, and Full Year 2025 revenue of$2,530.0 million , down 2% year-over-year - Fourth Quarter 2025 net loss of
$25.1 million , or$0.14 per share, and Full Year 2025 net loss of$200.3 million , or$1.14 per share - Fourth Quarter 2025 adjusted EBITDA of
$83.8 million , up 12% year-over-year, and Full Year 2025 adjusted EBITDA of$281.1 million , down 10% year-over-year - Full Year 2025 operating cash flow of
$294.4 million , flat year-over-year, and free cash flow of$166.9 million , down 2% year-over-year; ended the year with$781.1 million in cash and cash equivalents
“We closed 2025 with a solid finish, delivering consolidated revenue and adjusted EBITDA above the midpoint of our guidance ranges for the fourth quarter. I’m encouraged by the progress we made last year against each of our strategic priorities, as we strengthened our product portfolio, advanced innovation across Integrated Care and BetterHelp, and positioned the company to build on this momentum in 2026,” said
“Our focus remains on disciplined execution and performance acceleration as we progress through the year, with a clear commitment to advancing care and delivering better outcomes. Through continued product innovation and by leveraging advancements in our technology, we are strengthening our ability to meet the evolving needs of our clients and members to support sustainable growth over time.”
| Key Financial Data | |||||||||||||||||||||
| ($ in thousands, except per share data, unaudited) | |||||||||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||||||||
| 2025 | 2024 | Change | 2025 | 2024 | Change | ||||||||||||||||
| Revenue | $ | 642,269 | $ | 640,491 | — | % | $ | 2,529,977 | $ | 2,569,574 | (2 | )% | |||||||||
| Net loss | $ | (25,143 | ) | $ | (48,409 | ) | 48 | % | $ | (200,322 | ) | $ | (1,001,245 | ) | 80 | % | |||||
| Net loss per share, basic and diluted | $ | (0.14 | ) | $ | (0.28 | ) | 50 | % | $ | (1.14 | ) | $ | (5.87 | ) | 81 | % | |||||
| Adjusted EBITDA (1) | $ | 83,782 | $ | 74,835 | 12 | % | $ | 281,095 | $ | 310,711 | (10 | )% | |||||||||
See note (1) in the Notes section that follows.
Fourth Quarter 2025
Revenue of
Integrated
Net loss totaled
Results for Fourth Quarter 2024 primarily included amortization of intangible assets of
Adjusted EBITDA(1) increased 12% to
Full Year 2025
Revenue decreased 2% to
Integrated
Net loss totaled
The non-cash goodwill impairment charges recorded for Full Year 2025 were the result of the fair value of the Integrated Care segment being less than its carrying value at the time of the acquisitions of
Results for Full Year 2024 primarily included a non-cash goodwill impairment charge of
Adjusted EBITDA(1) decreased 10% to
Capex and Cash Flow
Cash flow from operations was
Financial Outlook
The outlook provided below is based on current market conditions and expectations and what we know today.
| For the full year of 2026, we expect: | |
| Full Year 2026 | |
| Revenue | |
| Adjusted EBITDA | |
| Net loss per share | ( |
| Free Cash Flow | |
| 97 - 100 million | |
| Integrated | |
| Revenue growth percentage (year-over-year) | 0.40% - 3.90% |
| Adjusted EBITDA margin | 15.10% - 16.10% |
| BetterHelp | |
| Revenue growth percentage (year-over-year) | (7.00%) - (0.50%) |
| Adjusted EBITDA margin | 3.00% - 4.60% |
| For the first quarter of 2026, we expect: | |
| 1Q 2026 | |
| Revenue | |
| Adjusted EBITDA | |
| Net loss per share | ( |
| 99 - 100 million | |
| Integrated | |
| Revenue growth percentage (year-over-year) | (1.20%) - 2.00% |
| Adjusted EBITDA margin | 12.50% - 14.00% |
| BetterHelp | |
| Revenue growth percentage (year-over-year) | (11.25%) - (7.00%) |
| Adjusted EBITDA margin | 0.75% - 2.75% |
See note (2) in the Notes section that follows.
Earnings Conference Call
The Fourth Quarter and Full Year 2025 earnings conference call and webcast will be held
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings, including our ability to effectively compete; (iii) results of litigation or regulatory actions; (iv) the loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users; (v) changes in valuations or useful lives of our assets; (vi) changes to our abilities to recruit and retain qualified providers into our network; (vii) the impact of and risk related to impairment losses with respect to goodwill or other assets; (viii) the success of our initiatives to improve our efficiency and competitiveness; and (ix) imposed and threatened tariffs by
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except share and per share data, unaudited) | |||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenue | $ | 642,269 | $ | 640,491 | $ | 2,529,977 | $ | 2,569,574 | |||||||
| Costs and expenses: | |||||||||||||||
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 197,048 | 188,928 | 771,593 | 751,270 | |||||||||||
| Advertising and marketing | 149,655 | 174,726 | 653,372 | 705,787 | |||||||||||
| Sales | 47,665 | 52,726 | 194,518 | 204,993 | |||||||||||
| Technology and development | 71,608 | 76,752 | 277,922 | 307,274 | |||||||||||
| General and administrative | 108,422 | 99,996 | 431,891 | 435,490 | |||||||||||
| — | — | 71,763 | 790,000 | ||||||||||||
| Acquisition, integration, and transformation costs | 2,233 | 456 | 9,010 | 1,743 | |||||||||||
| Restructuring costs | 6,796 | 5,602 | 18,785 | 20,355 | |||||||||||
| Amortization of intangible assets | 92,039 | 86,540 | 350,764 | 363,365 | |||||||||||
| Depreciation of property and equipment | 2,800 | 2,980 | 13,314 | 10,183 | |||||||||||
| Total costs and expenses | 678,266 | 688,706 | 2,792,932 | 3,590,460 | |||||||||||
| Loss from operations | (35,997 | ) | (48,215 | ) | (262,955 | ) | (1,020,886 | ) | |||||||
| Interest income | (6,951 | ) | (14,231 | ) | (36,770 | ) | (57,071 | ) | |||||||
| Interest expense | 4,950 | 6,846 | 19,714 | 23,803 | |||||||||||
| Other expense (income), net | (378 | ) | 7,341 | (10,369 | ) | 6,035 | |||||||||
| Loss before provision for income taxes | (33,618 | ) | (48,171 | ) | (235,530 | ) | (993,653 | ) | |||||||
| Provision for income taxes | (8,475 | ) | 238 | (35,208 | ) | 7,592 | |||||||||
| Net loss | $ | (25,143 | ) | $ | (48,409 | ) | $ | (200,322 | ) | $ | (1,001,245 | ) | |||
| Net loss per share, basic and diluted | $ | (0.14 | ) | $ | (0.28 | ) | $ | (1.14 | ) | $ | (5.87 | ) | |||
| Weighted-average shares used to compute basic and diluted net loss per share | 177,831,580 | 172,765,307 | 176,221,530 | 170,564,088 | |||||||||||
Stock-based Compensation Summary
Compensation expense for stock-based awards was classified as follows (in thousands, unaudited):
| Three Months Ended | Year Ended | ||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately) | $ | 494 | $ | 1,000 | $ | 2,082 | $ | 4,782 | |||
| Advertising and marketing | 1,006 | 1,552 | 4,894 | 12,575 | |||||||
| Sales | 2,808 | 4,683 | 13,817 | 24,807 | |||||||
| Technology and development | 3,316 | 7,721 | 17,477 | 34,855 | |||||||
| General and administrative | 8,287 | 12,516 | 42,144 | 68,932 | |||||||
| Total stock-based compensation expense (3) | $ | 15,911 | $ | 27,472 | $ | 80,414 | $ | 145,951 | |||
See note (3) in the Notes section that follows.
Revenues
| Three Months Ended | Year Ended | ||||||||||||||||
| ($ in thousands, unaudited) | 2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||
| Revenue by Type | |||||||||||||||||
| Access Fees | $ | 521,595 | $ | 543,123 | (4 | )% | $ | 2,091,941 | $ | 2,215,220 | (6 | )% | |||||
| Other | 120,674 | 97,368 | 24 | % | 438,036 | 354,354 | 24 | % | |||||||||
| Total Revenue | $ | 642,269 | $ | 640,491 | — | % | $ | 2,529,977 | $ | 2,569,574 | (2 | )% | |||||
| Revenue by Geography | |||||||||||||||||
| $ | 517,306 | $ | 535,396 | (3 | )% | $ | 2,071,739 | $ | 2,159,959 | (4 | )% | ||||||
| International Revenue | 124,963 | 105,095 | 19 | % | 458,238 | 409,615 | 12 | % | |||||||||
| Total Revenue | $ | 642,269 | $ | 640,491 | — | % | $ | 2,529,977 | $ | 2,569,574 | (2 | )% | |||||
Summary Operating Metrics
Consolidated
| Three Months Ended | Year Ended | ||||||||||
| (In millions) | 2025 | 2024 | Change | 2025 | 2024 | Change | |||||
| Total Visits | 4.3 | 4.4 | (1)% | 17.1 | 17.3 | (1)% | |||||
Integrated
| As of | ||||||
| (In millions) | 2025 | 2024 | Change | |||
| 101.8 | 93.8 | 9 | % | |||
| Chronic Care Program Enrollment (4) | 1.188 | 1.203 | (1 | )% | ||
| Three Months Ended | Year Ended | ||||||||||||||||
| 2025 | 2024 | Change | 2025 | 2024 | Change | ||||||||||||
| Average Monthly Revenue Per | $ | 1.34 | $ | 1.39 | (4 | )% | $ | 1.29 | $ | 1.37 | (6 | )% | |||||
BetterHelp
| Average for | Average for | ||||||||||||
| Three Months Ended | Year Ended | ||||||||||||
| (In millions) | 2025 | 2024 | Change | 2025 | 2024 | Change | |||||||
| BetterHelp Paying Users (6) | 0.375 | 0.400 | (6 | )% | 0.386 | 0.405 | (5 | )% | |||||
See notes (2), (4), (5), and (6) in the Notes section that follows.
Operating Results by Segment (see note (7) in the Notes section that follows)
The following table presents operating results by reportable segment for the periods indicated:
| Three Months Ended | Year Ended | ||||||||||||||||||||
| ($ in thousands, unaudited) | 2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||
| Integrated | |||||||||||||||||||||
| Revenue | $ | 409,094 | $ | 390,672 | 5 | % | $ | 1,579,610 | $ | 1,528,870 | 3 | % | |||||||||
| Adjusted EBITDA | $ | 65,325 | $ | 53,161 | 23 | % | $ | 239,222 | $ | 232,902 | 3 | % | |||||||||
| Adjusted EBITDA Margin % | 16.0 | % | 13.6 | % | 15.1 | % | 15.2 | % | |||||||||||||
| BetterHelp | |||||||||||||||||||||
| Therapy Services | $ | 229,056 | $ | 244,352 | (6) % | $ | 930,700 | $ | 1,017,725 | (9) % | |||||||||||
| Other Wellness Services | 4,119 | 5,467 | (25) % | 19,667 | 22,979 | (14) % | |||||||||||||||
| Total Revenue | $ | 233,175 | $ | 249,819 | (7) % | $ | 950,367 | $ | 1,040,704 | (9) % | |||||||||||
| Adjusted EBITDA | $ | 18,457 | $ | 21,674 | (15) % | $ | 41,873 | $ | 77,809 | (46) % | |||||||||||
| Adjusted EBITDA Margin % | 7.9 | % | 8.7 | % | 4.4 | % | 7.5 | % | |||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands, unaudited) | |||||||
| Year Ended | |||||||
| 2025 | 2024 | ||||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (200,322 | ) | $ | (1,001,245 | ) | |
| Adjustments to reconcile net loss to net cash flows from operating activities: | |||||||
| 71,763 | 790,000 | ||||||
| Amortization of intangible assets | 350,764 | 363,365 | |||||
| Stock-based compensation | 80,414 | 145,951 | |||||
| Depreciation of property and equipment | 13,314 | 10,183 | |||||
| Amortization of right-of-use assets | 12,356 | 9,295 | |||||
| Provision for allowances for doubtful accounts | 1 | 3,795 | |||||
| Deferred income taxes | (41,407 | ) | (1,145 | ) | |||
| Other, net | 6,399 | 9,796 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | 25,126 | (375 | ) | ||||
| Prepaid expenses and other current assets | 6,688 | 5,188 | |||||
| Inventory | 399 | (9,749 | ) | ||||
| Other assets | 7,997 | (1,257 | ) | ||||
| Accounts payable | 11,454 | (10,365 | ) | ||||
| Accrued expenses and other current liabilities | (22,984 | ) | 30,178 | ||||
| Accrued compensation | 13,296 | (20,499 | ) | ||||
| Deferred revenue | (19,762 | ) | (18,246 | ) | |||
| Operating lease liabilities | (13,628 | ) | (10,892 | ) | |||
| Other liabilities | (7,511 | ) | (298 | ) | |||
| Net cash provided by operating activities | 294,357 | 293,680 | |||||
| Cash flows from investing activities: | |||||||
| Capital expenditures | (8,893 | ) | (10,790 | ) | |||
| Capitalized software development costs | (118,562 | ) | (113,262 | ) | |||
| Proceeds from the sale of investment | 740 | — | |||||
| Acquisitions accounted for as business combinations, net of cash acquired | (81,904 | ) | — | ||||
| Asset acquisition resulting in net intangible assets | (29,569 | ) | — | ||||
| Payments for investments | (27,875 | ) | — | ||||
| Other, net | 60 | — | |||||
| Net cash used in investing activities | (266,003 | ) | (124,052 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from the exercise of stock options | 85 | 3,566 | |||||
| Proceeds from employee stock purchase plan | 3,000 | 4,748 | |||||
| Repayment of convertible senior notes | (550,629 | ) | — | ||||
| Payment of credit facility issuance costs | (4,108 | ) | — | ||||
| Other, net | — | (2 | ) | ||||
| Net cash (used in) provided by financing activities | (551,652 | ) | 8,312 | ||||
| Net (decrease) increase in cash and cash equivalents | (523,298 | ) | 177,940 | ||||
| Effect of foreign currency exchange rate changes | 6,055 | (3,288 | ) | ||||
| Cash and cash equivalents at beginning of the period | 1,298,327 | 1,123,675 | |||||
| Cash and cash equivalents at end of the period | $ | 781,084 | $ | 1,298,327 | |||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data, unaudited) | |||||||
2025 | 2024 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 781,084 | $ | 1,298,327 | |||
| Accounts receivable, net of allowance for doubtful accounts of | 192,826 | 214,146 | |||||
| Inventories | 38,203 | 38,138 | |||||
| Prepaid expenses and other current assets | 107,016 | 113,296 | |||||
| Total current assets | 1,119,129 | 1,663,907 | |||||
| Property and equipment, net | 26,972 | 29,487 | |||||
| 283,190 | 283,190 | ||||||
| Intangible assets, net | 1,297,087 | 1,431,360 | |||||
| Operating lease—right-of-use assets | 26,119 | 27,092 | |||||
| Other assets | 105,803 | 81,488 | |||||
| Total assets | $ | 2,858,300 | $ | 3,516,524 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 47,967 | $ | 33,130 | |||
| Accrued expenses and other current liabilities | 198,208 | 202,157 | |||||
| Accrued compensation | 96,258 | 76,229 | |||||
| Deferred revenue—current | 62,305 | 79,296 | |||||
| Convertible senior notes, net—current | — | 550,723 | |||||
| Total current liabilities | 404,738 | 941,535 | |||||
| Other liabilities | 643 | 720 | |||||
| Operating lease liabilities, net of current portion | 34,204 | 32,135 | |||||
| Deferred revenue, net of current portion | 9,139 | 9,786 | |||||
| Deferred taxes, net | 28,945 | 49,851 | |||||
| Convertible senior notes, net—non-current | 994,925 | 991,418 | |||||
| Total liabilities | 1,472,594 | 2,025,445 | |||||
| Commitments and contingencies | |||||||
| Stockholders’ equity: | |||||||
| Common stock, | 178 | 173 | |||||
| Additional paid-in capital | 17,850,478 | 17,759,194 | |||||
| Accumulated deficit | (16,430,222 | ) | (16,229,900 | ) | |||
| Accumulated other comprehensive loss | (34,728 | ) | (38,388 | ) | |||
| Total stockholders’ equity | 1,385,706 | 1,491,079 | |||||
| Total liabilities and stockholders’ equity | $ | 2,858,300 | $ | 3,516,524 | |||
Non-GAAP Financial Measures:
To supplement our financial information presented in accordance with generally accepted accounting principles in
Adjusted EBITDA consists of net loss before provision for income taxes; other expense (income), net; interest income; interest expense; depreciation of property and equipment; amortization of intangible assets; restructuring costs; acquisition, integration, and transformation cost; goodwill impairments; and stock-based compensation.
Free cash flow is net cash provided by operating activities less capital expenditures and capitalized software development costs.
Our use of these non-GAAP terms may vary from that of others in our industry, and other companies may calculate such measures differently than we do, limiting their usefulness as comparative measures.
Non-GAAP measures have important limitations as analytical tools and you should not consider them in isolation, and they should not be considered as an alternative to net loss before provision for income taxes, net loss, net loss per share, net cash from operating activities or any other measures derived in accordance with GAAP. Some of these limitations are:
- adjusted EBITDA eliminates the impact of the provision for income taxes on our results of operations, and does not reflect other expense (income), net, interest income, or interest expense;
- adjusted EBITDA does not reflect restructuring costs. Restructuring costs may include certain lease impairment costs, certain losses related to early lease terminations, and severance;
- adjusted EBITDA does not reflect significant acquisition, integration, and transformation costs. Acquisition, integration, and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration, and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including upgrading our customer relationship management and enterprise resource planning systems. These transformation cost adjustments made to our results do not represent normal, recurring, operating expenses necessary to operate the business but, rather, incremental costs incurred in connection with our acquisition and integration activities;
- adjusted EBITDA does not reflect goodwill impairment charges; and
- adjusted EBITDA does not reflect the significant non-cash stock-based compensation expense which should be viewed as a component of recurring operating costs.
In addition, although amortization of intangible assets and depreciation of property and equipment are non-cash charges, the assets being amortized and depreciated will often have to be replaced in the future, and adjusted EBITDA does not reflect any expenditures for such replacements.
We compensate for these limitations by using these non-GAAP measures along with other comparative tools, together with GAAP measurements, to assist in the evaluation of operating performance. Such GAAP measurements include net loss, net loss per share, net cash provided by operating activities, and other performance measures.
In evaluating these financial measures, you should be aware that in the future we may incur expenses similar to those eliminated in this presentation. Our presentation of these non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.
The following is a reconciliation of net loss, the most directly comparable GAAP financial measure, to adjusted EBITDA:
| Reconciliation of GAAP Net Loss to Adjusted EBITDA (In thousands, unaudited) | |||||||||||||||||||
| Outlook in millions (8) | |||||||||||||||||||
| Three Months Ended | Year Ended | First Quarter | Full Year | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | 2026 | 2026 | ||||||||||||||
| Net loss | $ | (25,143 | ) | $ | (48,409 | ) | $ | (200,322 | ) | $ | (1,001,245 | ) | |||||||
| Add: | |||||||||||||||||||
| Provision for income taxes | (8,475 | ) | 238 | (35,208 | ) | 7,592 | |||||||||||||
| Other expense (income), net | (378 | ) | 7,341 | (10,369 | ) | 6,035 | |||||||||||||
| Interest expense | 4,950 | 6,846 | 19,714 | 23,803 | |||||||||||||||
| Interest income | (6,951 | ) | (14,231 | ) | (36,770 | ) | (57,071 | ) | |||||||||||
| Depreciation of property and equipment | 2,800 | 2,980 | 13,314 | 10,183 | |||||||||||||||
| Amortization of intangible assets | 92,039 | 86,540 | 350,764 | 363,365 | |||||||||||||||
| Restructuring costs | 6,796 | 5,602 | 18,785 | 20,355 | |||||||||||||||
| Acquisition, integration, and transformation costs | 2,233 | 456 | 9,010 | 1,743 | |||||||||||||||
| — | — | 71,763 | 790,000 | ||||||||||||||||
| Stock-based compensation | 15,911 | 27,472 | 80,414 | 145,951 | |||||||||||||||
| Total Adjustments | 108,925 | 123,244 | 481,417 | 1,311,956 | 113 - 143 | 393 - 508 | |||||||||||||
| Consolidated Adjusted EBITDA | $ | 83,782 | $ | 74,835 | $ | 281,095 | $ | 310,711 | |||||||||||
| Segment Adjusted EBITDA | |||||||||||||||||||
| Integrated | $ | 65,325 | $ | 53,161 | $ | 239,222 | $ | 232,902 | |||||||||||
| BetterHelp | 18,457 | 21,674 | 41,873 | 77,809 | |||||||||||||||
| Consolidated Adjusted EBITDA | $ | 83,782 | $ | 74,835 | $ | 281,095 | $ | 310,711 | |||||||||||
See note (8) in the Notes section that follows.
The following is a reconciliation of net cash provided by operating activities, the most directly comparable GAAP financial measure, to free cash flow:
| Reconciliation of GAAP Net Cash Provided by Operating Activities to Free Cash Flow (In thousands, unaudited) | |||||||||||||||||
| Three Months Ended | Year Ended | Outlook (9) | |||||||||||||||
| Full Year | |||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | 2026 (in millions) | |||||||||||||
| Net cash provided by operating activities | $ | 87,742 | $ | 85,902 | $ | 294,357 | $ | 293,680 | |||||||||
| Capital expenditures | (2,619 | ) | (6,132 | ) | (8,893 | ) | (10,790 | ) | |||||||||
| Capitalized software development costs | (31,700 | ) | (23,512 | ) | (118,562 | ) | (113,262 | ) | |||||||||
| Capex | (34,319 | ) | (29,644 | ) | (127,455 | ) | (124,052 | ) | (130) - (120) | ||||||||
| Free Cash Flow | $ | 53,423 | $ | 56,258 | $ | 166,902 | $ | 169,628 | |||||||||
See note (9) in the Notes section that follows.
Notes:
- A reconciliation of each non-GAAP measure to the most comparable measure under GAAP has been provided in this press release in the accompanying tables. An explanation of these non-GAAP measures is also included under the heading “Non-GAAP Financial Measures.”
U.S. Integrated Care Members represent the number of unique individuals who have paid access and visit fee only access to our suite of integrated care services in theU.S. at the end of the applicable period.- Excluding the amount capitalized related to software development projects.
- Chronic Care Program Enrollment represents the total number of enrollees across our suite of chronic care programs at the end of the applicable period.
- Average monthly revenue per
U.S. IntegratedCare member is calculated by dividing the total revenue generated from the Integrated Care segment by the average number ofU.S. Integrated Care Members (see note 2) during the applicable period. - BetterHelp Paying Users represent the average number of global monthly paying users of our BetterHelp therapy services during the applicable period, including both those who pay directly out-of-pocket and those who utilize their insurance coverage.
- We have two segments: Integrated Care and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment includes virtual therapy and other wellness services provided on a global basis which are predominantly marketed and sold on a direct-to-consumer basis.
- We have not provided a full line-item reconciliation for net loss to adjusted EBITDA outlook because we do not provide outlook on the individual reconciling items between net loss and adjusted EBITDA. This is due to the uncertainty as to timing, and the potential variability, of the individual reconciling items such as impairments, stock-based compensation and the related tax impact, provision for income taxes, acquisition, integration, and transformation costs, and restructuring costs, the effect of which may be significant. Accordingly, a full line-item reconciliation of the GAAP measure to the corresponding non-GAAP financial measure outlook is not available without unreasonable effort.
- We have not provided a line-item reconciliation for free cash flow to net cash from operating activities for this future period because we believe such a reconciliation would imply a degree of precision and certainty that could be confusing to investors and we are unable to reasonably predict certain items contained in the GAAP measure without unreasonable effort.
Investors:
617-444-9612
ir@teladochealth.com
Media:
202-569-9715
pr@teladochealth.com
